Laure Bindels

Background

About Laure Bindels

Dr. Laure Bindels obtained the title of pharmacist and completed her PhD training as an FNRS fellow at the Université catholique de Louvain in Belgium. Her PhD research established the therapeutic potential of prebiotics and probiotics in managing tumor progression and associated cachexia. During her postdoctoral tenure at the University of Nebraska-Lincoln in the USA, she demonstrated that resistant starches can enhance insulin sensitivity independently of the gut microbiota. During this time, she trained herself in bioinformatics and biostatistics. Currently, Dr. Bindels serves as an Associate Professor at the Université catholique de Louvain and is a WELRI investigator. She is an internationally recognized expert in the mechanisms linking the gut microbiota with cancer cachexia and metabolic and inflammatory disorders, a research focus she is exploring with her team. She is also a lecturer at the Faculty of Pharmaceutical and Biomedical Sciences where her current teaching topics include toxicology, nutrition, cancer, analytical chemistry and drug metabolism. Dr. Bindels has received numerous accolades, including the Collen-Francqui Research Professor Mandate (2022-2025), the Galien Prize (2024), the Bekales Prize (2024), the Dr. Maes Prize (2023) and the Pharmabiotics Young Investigators Award (2018). Additionally, she holds editorial positions as an Associate Editor for JCSM and Senior Editor for Microbiome and acts as a Board Director for the Cancer Cachexia Society.